Literature DB >> 19064283

The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.

Zagit Z Gaymalov1, Zhihui Yang, Vladimir M Pisarev, Valery Yu Alakhov, Alexander V Kabanov.   

Abstract

DNA vaccines can be greatly improved by polymer agents that simultaneously increase transgene expression and activate immunity. We describe here Pluronic P85 (P85), a triblock copolymer of ethylene oxide (EO) and propylene oxide (PO) EO(26)-PO(40)-EO(26). Using a mouse model we demonstrate that co-administration of a bacterial plasmid DNA with P85 in a skeletal muscle greatly increases gene expression in the injection site and distant organs, especially the draining lymph nodes and spleen. The reporter expression colocalizes with the specific markers of myocytes and keratinocytes in the muscle, as well as dendritic cells (DCs) and macrophages in the muscle, lymph nodes and spleen. Furthermore, DNA/P85 and P85 alone increase the systemic expansion of CD11c+ (DC), and local expansion of CD11c+, CD14+ (macrophages) and CD49b+ (natural killer) cell populations. DNA/P85 (but not P85) also increases maturation of local DC (CD11c+ CD86+, CD11c+ CD80 +, and CD11c+ CD40+. We suggest that DNA/P85 promotes the activation and recruitment of the antigen-presenting cells, which further incorporate, express and carry the transgene to the immune system organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064283      PMCID: PMC2667955          DOI: 10.1016/j.biomaterials.2008.10.064

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  88 in total

1.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

2.  Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer.

Authors:  I Astafieva; I Maksimova; E Lukanidin; V Alakhov; A Kabanov
Journal:  FEBS Lett       Date:  1996-07-08       Impact factor: 4.124

3.  IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

Authors:  K Q Xin; K Hamajima; S Sasaki; T Tsuji; S Watabe; E Okada; K Okuda
Journal:  Vaccine       Date:  1999-02-26       Impact factor: 3.641

4.  Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; Donald W Miller; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

5.  Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.

Authors:  Mi Lan Kang; Hu-Lin Jiang; Sang Gyun Kang; Ding Ding Guo; Deog Yong Lee; Chong-Su Cho; Han Sang Yoo
Journal:  Vaccine       Date:  2007-04-09       Impact factor: 3.641

6.  GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines.

Authors:  Miguel-Angel Perales; Giamila Fantuzzi; Stacie M Goldberg; Mary Jo Turk; Fariborz Mortazavi; Klaus Busam; Alan N Houghton; Charles A Dinarello; Jedd D Wolchok
Journal:  Cytokines Cell Mol Ther       Date:  2002

Review 7.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.

Authors:  A C Allison; N E Byars
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

Review 8.  GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.

Authors:  Vincent G Brichard; Diane Lejeune
Journal:  Vaccine       Date:  2007-09-27       Impact factor: 3.641

9.  Histamine release from human basophils by synthetic block co-polymers composed of polyoxyethylene and polyoxypropylene and synergy with immunologic and non-immunologic stimuli.

Authors:  T P Atkinson; T F Smith; R L Hunter
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

10.  Adjuvant formulations and their mode of action.

Authors:  A C Allison; N E Byars
Journal:  Semin Immunol       Date:  1990-09       Impact factor: 11.130

View more
  17 in total

1.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

2.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

3.  Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Authors:  Neeta Jain-Gupta; Araceli Contreras-Rodriguez; Ramesh Vemulapalli; Sharon G Witonsky; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  FEMS Immunol Med Microbiol       Date:  2012-12

4.  Poly(alkylene oxide) copolymers for nucleic acid delivery.

Authors:  Swati Mishra; Lavanya Y Peddada; David I Devore; Charles M Roth
Journal:  Acc Chem Res       Date:  2012-01-19       Impact factor: 22.384

Review 5.  Endocytosis of nanomedicines.

Authors:  Gaurav Sahay; Daria Y Alakhova; Alexander V Kabanov
Journal:  J Control Release       Date:  2010-03-10       Impact factor: 9.776

6.  Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid.

Authors:  Yong Diao; Xiao-Feng Zhao; Jun-Sheng Lin; Qi-Zhao Wang; Rui-An Xu
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

7.  Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.

Authors:  Nitin K Swarnakar; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200

8.  The utilization of pathogen-like cellular trafficking by single chain block copolymer.

Authors:  Gaurav Sahay; Vivek Gautam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Biomaterials       Date:  2009-12-05       Impact factor: 12.479

9.  Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

Authors:  Elena V Batrakova; Shu Li; Anna M Brynskikh; Amit K Sharma; Yili Li; Michael Boska; Nan Gong; R Lee Mosley; Valery Yu Alakhov; Howard E Gendelman; Alexander V Kabanov
Journal:  J Control Release       Date:  2010-01-13       Impact factor: 9.776

10.  SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Authors:  Sophie Bouyon; Véronique Roussel; Yves Fromes
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.